EirGenix (6589) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.020x

Based on the latest financial reports, EirGenix (6589) has a cash flow conversion efficiency ratio of -0.020x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-168.94 Million ≈ $-5.32 Million USD) by net assets (NT$8.46 Billion ≈ $266.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of EirGenix to measure how many days the company can operate on defensive assets alone.

EirGenix - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how EirGenix's cash flow conversion efficiency has evolved over time, based on yearly financial data.

EirGenix Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EirGenix ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Jiaoda Onlly Co Ltd SHG:600530	0.031x
Hovnanian Enterprises Inc NYSE:HOV	-0.081x
Beijing Vastdata Technology Co Ltd SHG:603138	-0.015x
First Community Bancshares Inc NASDAQ:FCBC	0.037x
SENORES PHARMACEUTICALS L NSE:SENORES	0.029x
APG SGA SA SW:APGN	0.000x
Catapult Group International Ltd AU:CAT	0.334x
Sichuan Discovery Dream Science & Technology Co.Ltd SHE:301213	N/A

Annual Cash Flow Conversion Efficiency for EirGenix (2017–2024)

The table below shows the annual cash flow conversion efficiency of EirGenix from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of EirGenix.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$9.26 Billion ≈ $291.69 Million	NT$-311.44 Million ≈ $-9.81 Million	-0.034x	+60.29%
2023-12-31	NT$10.02 Billion ≈ $315.61 Million	NT$-848.56 Million ≈ $-26.73 Million	-0.085x	-513.43%
2022-12-31	NT$10.68 Billion ≈ $336.57 Million	NT$-147.52 Million ≈ $-4.65 Million	-0.014x	-381.65%
2021-12-31	NT$10.43 Billion ≈ $328.56 Million	NT$-29.90 Million ≈ $-941.98K	-0.003x	+98.70%
2020-12-31	NT$1.91 Billion ≈ $60.04 Million	NT$-419.26 Million ≈ $-13.21 Million	-0.220x	+7.36%
2019-12-31	NT$3.30 Billion ≈ $104.01 Million	NT$-784.07 Million ≈ $-24.70 Million	-0.237x	-6.49%
2018-12-31	NT$2.09 Billion ≈ $65.77 Million	NT$-465.61 Million ≈ $-14.67 Million	-0.223x	-34.68%
2017-12-31	NT$1.14 Billion ≈ $36.07 Million	NT$-189.57 Million ≈ $-5.97 Million	-0.166x	--

About EirGenix

TWO:6589 Taiwan Biotechnology

Market Cap

$632.48 Million

NT$20.08 Billion TWD

Market Cap Rank

#11100 Global

#417 in Taiwan

Share Price

NT$66.40

Change (1 day)

+0.45%

52-Week Range

NT$61.40 - NT$66.40

All Time High

NT$188.50